TNF Inhibitors and Risk of Malignancy in Patients with Inflammatory Bowel Diseases: A Systematic Review. Muller M, D'Amico F, Bonovas S, Danese S, et al. J Crohns Colitis 2021;15:840-859.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Muller M, D'Amico F, Bonovas S, Danese S, et al. TNF Inhibitors and Risk of Malignancy in Patients with Inflammatory Bowel Diseases: A Systematic Review. J Crohns Colitis 2021;15:840-859.
PMID: 32915970